Charles River Laboratories Officer Files Form 144 to Sell $742K in Common Stock Under Rule 10b5-1 Plan
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subscribe to track CRL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Proposed sale of 2,156 shares ($742,548) by Officer Shannon M. Parisotto via Rule 10b5-1 trading plan adopted on March 4, 2026.
Comprehensive Analysis
Transaction Overview
On October 21, 2026, Shannon M. Parisotto, an Officer at Charles River Laboratories International, Inc. ($CRL), filed a Form 144 notice disclosing the intent to sell 2,156 shares of common stock with an aggregate market value of approximately $742,548. The shares originate from a same-day exercise of stock options paid in cash.
Key Filing Details
- Filer: Shannon M. Parisotto (Officer)
- Shares Offered: 2,156 common shares
- Approximate Sale Value: $742,547.96 (~$344.41 per share)
- Shares Outstanding: 47,738,872 shares
- Broker: UBS Financial Services, Inc.
- Trading Plan: Pre-scheduled under a Rule 10b5-1 plan adopted on March 4, 2026.
Prior Sales in Preceding 3 Months
Over the past three months, the insider executed multiple sales under the trading plan:
- 10/05/2026: 981 shares for $302,579.64
- 08/19/2026: 2,039 shares for $599,710.68
- 08/11/2026: 3,714 shares for $1,038,657.24
- 08/05/2026: 5,046 shares for $1,327,098.00
Significance Assessment
The market impact is rated as Low. The proposed sale represents a negligible fraction of the company's 47.7M outstanding shares, stems from an option exercise, and is conducted pursuant to a pre-established Rule 10b5-1 plan established in March 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
